Imagine a companion who is able to constantly motivate you, actively encourages you and changes your bad habits into healthy ones. A companion who is always present and who tries to aid you and offer advice or intervention when needed. Therapists and doctors strive to achieve this, but quite often, it isn't a realistic goal.

A national focus on reducing avoidable patient harm in NHS hospitals is to benefit from a new collaboration between two vital signs monitoring and technology specialists, which should significantly help doctors and nurses in their quest to deliver safer care.

Medelinked, the global online and mobile health platform that empowers healthcare engagement and management, today announced it has enhanced the potential for collaboration between doctors and other healthcare professionals.

Startupbootcamp Digital Health Berlin is a dedicated accelerator for innovative startups that combine medical knowledge with smart technologies, with special focus on behavior change, diagnostics and genomics, big data and analytics. The program provides mentorship, funding, logistic support and access to our huge network of industry specific mentors, corporate partners, angels and VC's to up to 10 high potential Digital Health startups from around the world.

Health ministries and their agencies responsible for ICT systems from Austria, Catalonia, Denmark, Finland, Norway and Sweden today delivered a joint letter to the eHealth Network endorsing large scale deployment of telehealth systems, outlining challenges to implementation, and requesting support to address telehealth challenges related to enabling technology and interoperability.

Medelinked, the global online and mobile health platform that empowers healthcare engagement and management, has announced that the Medelinked mobile health app for Android and iOS will be available free to NHS patients, doctors and healthcare professionals.

Merck, a leading science and technology company, announced today that the company has entered into an agreement with HAPPYneuron, a subsidiary of SBT Group of France, in which Merck will receive an exclusive license to the company's cognitive remediation training program for people living with multiple sclerosis (MS).